Olanzapine, risperidone or quetiapine treatment initiation: 12-month schizophrenia outpatient health outcomes (SOHO) study results

Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/99010

Full metadata record

DC Field	Value	Language
dc.creator	D. Novick
dc.creator	J. Haro
dc.creator	M. Belger
dc.creator	S. Tzivelekis
dc.creator	J. Alonso
dc.creator	I. Gasquet
dc.creator	H. Kristensen
dc.creator	P. Jones
dc.creator	M. Knapp
dc.creator	J. Lepine
dc.creator	V. Mavreas
dc.creator	D. Murray
dc.creator	D. Naber
dc.creator	P. Pancheri
dc.creator	C. Slooff
dc.creator	João Marques Teixeira
dc.date.accessioned	2022-09-11T08:57:27Z	-
dc.date.available	2022-09-11T08:57:27Z	-
dc.date.issued	2004
dc.identifier.other	sigarra:82640
dc.identifier.uri	https://hdl.handle.net/10216/99010	-
dc.language.iso	eng
dc.relation.ispartof	European Psychiatry, Vol.19, supl.1
dc.rights	restrictedAccess
dc.subject	Psicologia
dc.subject	Psychology
dc.title	Olanzapine, risperidone or quetiapine treatment initiation: 12-month schizophrenia outpatient health outcomes (SOHO) study results
dc.type	Resumo de Comunicação em Conferência Internacional
dc.contributor.uporto	Faculdade de Psicologia e de Ciências da Educação
dc.subject.fos	Ciências sociais::Psicologia
dc.subject.fos	Social sciences::Psychology
Appears in Collections:	FPCEUP - Resumo de Comunicação em Conferência Internacional

Files in This Item:

File	Description	Size	Format
82640.pdf Restricted Access		46.5 kB	Adobe PDF	View/Open